CASP2 and metabolic dysfunction-associated steatotic liver disease: Macroscopically, Casp2−/− mice were protected from HFD-induced NAFLD, whereas 10/16 HFD-fed WT mice had clear signs of hepatosteatosis (enlarged, white mottled liver), which was confirmed by histological analysis (Figure 2h).